 NEW YORK, Feb. 01, 2021 GLOBE NEWSWIRE -- MEDIROM Healthcare Technologies Inc. NasdaqCM:MRM, a holistic healthcare company from Japan the Company, announced today that it has completed the sale of an additional 60,000 ADSs each ADS representing one common share, no par value at the public offering price of US15.00 per ADS, pursuant to the exercise by the underwriter of the over-allotment option granted to it in connection with the Companys initial public offering. The Company expects to receive additional net proceeds of approximately US837,000, after underwriting discounts and commissions. 